These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21637049)

  • 1. Synchronous second primary neoplasms detected by initial staging F-18 FDG PET/CT examination in patients with non-Hodgkin lymphoma.
    Papajík T; Mysliveček M; Sedová Z; Buriánková E; Procházka V; Raida L; Kubová Z; Neoral C; Starostka D; Mikula P; Melichar B; Kučerová L; Tichý M; Indrák K
    Clin Nucl Med; 2011 Jul; 36(7):509-12. PubMed ID: 21637049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
    Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
    Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan versus diagnostic contrast computed tomography in initial staging of pediatric patients with lymphoma.
    Cheng G; Servaes S; Zhuang H
    Leuk Lymphoma; 2013 Apr; 54(4):737-42. PubMed ID: 22957898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of ¹⁸F-FDG PET/CT and large-scale DWI for evaluation of non-Hodgkin lymphoma bone marrow infiltration].
    Tang R; Gui S; Li J; Zhang H; Lu B; Yang P; Fu D; Fu W; Li W; Cai L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):231-5. PubMed ID: 24666490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUV on dual-phase FDG PET/CT correlates with the Ki-67 proliferation index in patients with newly diagnosed non-Hodgkin lymphoma.
    Chang CC; Cho SF; Chen YW; Tu HP; Lin CY; Chang CS
    Clin Nucl Med; 2012 Aug; 37(8):e189-95. PubMed ID: 22785526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin's lymphoma.
    Papajík T; Mysliveček M; Sedová Z; Buriánková E; Procházka V; Koranda P; Raida L; Kubová Z; Palová M; Kučerová L; Flodr P; Jarkovský J; Dušek L; Indrák K
    Eur J Haematol; 2011 Jan; 86(1):32-7. PubMed ID: 20874822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL).
    Najjar F; Hustinx R; Jerusalem G; Fillet G; Rigo P
    Cancer Biother Radiopharm; 2001 Aug; 16(4):297-304. PubMed ID: 11603000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of F-18 FDG PET/CT in non-Hodgkin lymphoma with central nervous system involvement.
    Cimarelli S; Sebban C; Thiesse P; Sunyach MP; Blay JY; Ghesquières H
    Clin Nucl Med; 2011 Jun; 36(6):e45-9. PubMed ID: 21552016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma.
    Hernandez-Maraver D; Hernandez-Navarro F; Gomez-Leon N; Coya J; Rodriguez-Vigil B; Madero R; Pinilla I; Martin-Curto LM
    Br J Haematol; 2006 Nov; 135(3):293-302. PubMed ID: 17032175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma.
    Haerle SK; Strobel K; Hany TF; Sidler D; Stoeckli SJ
    Head Neck; 2010 Mar; 32(3):319-25. PubMed ID: 19626642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
    Moog F; Bangerter M; Diederichs CG; Guhlmann A; Kotzerke J; Merkle E; Kolokythas O; Herrmann F; Reske SN
    Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of secondary central nervous system involvement in patients with non-Hodgkin's lymphoma as detected by 18F-FDG PET/CT.
    Akkas BE; Vural GU
    Nucl Med Commun; 2013 Jan; 34(1):50-6. PubMed ID: 23111376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining the extent and stage of disease in patients with newly diagnosed non-Hodgkin's lymphoma using 18F-FDG-PET/CT.
    Papajik T; Myslivecek M; Skopalova M; Malan A; Buriankova E; Koza V; Hnatkova M; Trneny M; Sedova Z; Kubova Z; Koranda P; Flodr P; Jarkovsky J; Dusek L; Indrak K
    Neoplasma; 2011; 58(4):291-7. PubMed ID: 21524147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of FDG-PET in the Diagnosis and Staging of Ocular Adnexal Lymphoproliferative Disease.
    English JF; Sullivan TJ
    Orbit; 2015; 34(5):284-91. PubMed ID: 26308502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management impact of clinically significant incidental lesions detected on staging FDG PET-CT in patients with non-small cell lung cancer (NSCLC): an analysis of 649 cases.
    Lin M; Ambati C
    Lung Cancer; 2012 Jun; 76(3):344-9. PubMed ID: 22206598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
    Bumann D; de Wit M; Beyer W; Beese M; Lübeck M; Bücheler E; Clausen M
    Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (18)F-FDG PET-detected synchronous primary neoplasms in the staging of esophageal cancer: incidence, cost, and impact on management.
    Malik V; Johnston C; Donohoe C; Claxton Z; Lucey J; Ravi N; Reynolds JV
    Clin Nucl Med; 2012 Dec; 37(12):1152-8. PubMed ID: 23154472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
    Qiao W; Zhao J; Wang C; Wang T; Xing Y
    Hematology; 2010 Feb; 15(1):21-7. PubMed ID: 20132658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography for detection and staging of malignant lymphoma.
    Buchmann I; Moog F; Schirrmeister H; Reske SN
    Recent Results Cancer Res; 2000; 156():78-89. PubMed ID: 10802866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkin's lymphoma.
    Tatsumi M; Kitayama H; Sugahara H; Tokita N; Nakamura H; Kanakura Y; Nishimura T
    J Nucl Med; 2001 Apr; 42(4):601-8. PubMed ID: 11337549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.